- First proteinuria data on povetacicept in primary membranous nephropathy shows mean UPCR reduction from baseline of 62% at 24 weeks – - Global Phase 3 RAINIER trial of povetacicept in IgA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback